Search

for
Search:

Sort by

Research

30-60 / 1000+ results

Trazodone and Chlorpromazine: A Proposed Treatment for Post-Finasteride Syndrome and Post-SSRI Syndrome

research Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI)

July 2023 in “World Journal of Biology Pharmacy and Health Sciences”

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.

research 5-Alpha Reductase Inhibitors on Hypersexuality During the Manic Phase of Bipolar and Psychotic Patients; New Insight to a Well-Known Medicines

February 2025 in “Iranian journal of pharmaceutical research”

research Risk of finasteride-related suicidal ideation

September 2022 in “Reactions Weekly”

research Suicidal ideation with finasteride but not dutasteride

May 2025 in “Reactions Weekly”

research Diffuse Hair Loss Induced by Sertraline Use

3 citations , January 2015 in “Case reports in psychiatry”

Sertraline can cause hair loss, which stops after stopping the drug.

The 5α-Reductase Inhibitor Finasteride Increases Suicide-Related Aggressive Behaviors and Blocks Clozapine-Induced Beneficial Effects in an Animal Model of Schizophrenia

research The 5α-reductase inhibitor finasteride increases suicide-related aggressive behaviors and blocks clozapine-induced beneficial effects in an animal model of schizophrenia

12 citations , April 2018 in “Physiology & Behavior”

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

research Overexpression of the 18 kDa translocator protein (TSPO) in the hippocampal dentate gyrus produced anxiolytic and antidepressant-like behavioural effects

25 citations , June 2017 in “Neuropharmacology”

Increasing TSPO in the brain reduces anxiety and depression.

Post-Finasteride Syndrome and Post-SSRI Sexual Dysfunction: Two Clinically Similar Conditions

research POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE

November 2023 in “Frontiers in Neuroendocrinology”

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

research Reminder of finasteride-related psychiatric AEs and sexual dysfunction

May 2024 in “Reactions weekly”

research Med Check

May 2011 in “Psychiatric News”

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

research Depression risk of 5-alpha reductase inhibitors: A systematic review and meta-analysis with a focus on comparator groups

August 2025 in “medRxiv (Cold Spring Harbor Laboratory)”

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

UK High Court Revokes Escitalopram Patent; Validity of Second Medical Use Claims Based on Dosage Regimes; Stay of Proceedings Pending EPO Opposition

research UK High Court Revokes Escitalopram UK Patent; Validity of Second Medical use Claims Based on Dosage Regimes in the UK; Stay of Proceedings in the UK Courts Pending EPO Opposition Proceedings

July 2007 in “Journal of Generic Medicines”

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

research Finasteride-related depression and suicidal ideation

October 2025 in “Reactions Weekly”

research O impacto da COVID-19 no ciclo menstrual: uma perspectiva geral

March 2023 in “Brazilian Journal of Health Review”

The combination tablet of finasteride and doxazosin works the same as taking each drug separately.

Signal Detection Between 5-Alpha Reductase Inhibitors and the Risk of Suicidality and Depression: An International Pharmacovigilance Analysis

research Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis

1 citations , June 2025 in “European Journal of Clinical Pharmacology”

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Antidepressant-Like Effect of Fluoxetine May Depend on Translocator Protein Activity and Pretest Session Duration in Forced Swimming Test in Mice

research Antidepressant-like effect of fluoxetine may depend on translocator protein activity and pretest session duration in forced swimming test in mice

7 citations , October 2017 in “Behavioural Pharmacology”

Fluoxetine's effectiveness as an antidepressant in mice depends on a specific protein activity and a 5-minute pretest.

research Health Canada has approved finasteride [Proscar; Merck Frosst] and doxazosin cotherapy

September 2004 in “Inpharma Weekly”

research The anxiolytic-like effects of estazolam on a PTSD animal model

12 citations , August 2018 in “Psychiatry research”

Estazolam reduces anxiety-like behavior in PTSD by increasing allopregnanolone levels.

Summary of Findings on Psychotropic Medications

research Table of Contents

December 2006 in “The Brown University Psychopharmacology Update”

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

research Prescribers alerted to potential adverse effects of finasteride and montelukast

May 2024 in “News Digital Object Group”

research Finasteride/spironolactone

May 2024 in “Reactions weekly”

research Association of Suicidality and Depression With 5α-Reductase Inhibitors

90 citations , March 2017 in “JAMA Internal Medicine”

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.